The Stunning Golden Parachutes of Juno's $9B Celgene Deal Post author:Sam Post published:February 4, 2018 Post category:BioPharma Juno’s Hans Bishop will take home $287M after Celgene acquired his company. Source: BioSpace You Might Also Like OMEICOS Therapeutics Secures Extension Of Series B Financing Round To Expand Its Technology Into Ophthalmology October 4, 2017 Swedish Orphan AB – Elocta Approved In The Kingdom Of Saudi Arabia For The Treatment Of Haemophilia A May 17, 2017 Investors Antsy as Novartis AG Mulls Over Selling $50 Billion in Assets May 29, 2017
OMEICOS Therapeutics Secures Extension Of Series B Financing Round To Expand Its Technology Into Ophthalmology October 4, 2017
Swedish Orphan AB – Elocta Approved In The Kingdom Of Saudi Arabia For The Treatment Of Haemophilia A May 17, 2017
